ArticleBone marrow transplantation2013

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.

M Foglietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.